AGAP13P

Across TCGA pan-cancer cohorts, AGAP13P RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of AGAP13P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where AGAP13P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types AGAP13P is over-expressed in tumor, although a few such as BRCA and THCA show the opposite, repressed pattern.

KIRC, BRCA, and KIRP are the cancer types where AGAP13P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in AGAP13P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	All	All	+0.347	<.001	7	view →
BRCA	Female	All	−0.215	.007	4	view →
KIRP	All	IV	+0.867	.044	2	view →
THCA	All	II,III,IV	−0.387	.041	2	view →
PRAD	All	All	+0.272	.008	2	view →
COAD	Female	IV	+0.990	.012	1	view →
CHOL	All	All	+0.902	.012	1	view →
KICH	All	All	−0.236	.017	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

AGAP13P–KIRC

Open the KIRC breakdown →